These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges. Xiao B; Ng HH; Takahashi R; Tan EK J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):697-702. PubMed ID: 26833176 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells. Stoddard-Bennett T; Reijo Pera R Cells; 2019 Jan; 8(1):. PubMed ID: 30621042 [TBL] [Abstract][Full Text] [Related]
10. Stem cell therapies for Parkinson's disease: are trials just around the corner? Drouin-Ouellet J; Barker RA Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072 [No Abstract] [Full Text] [Related]
14. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment. Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765 [TBL] [Abstract][Full Text] [Related]
15. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant. Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410 [TBL] [Abstract][Full Text] [Related]
16. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease. Chen W; Huang Q; Ma S; Li M ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716 [TBL] [Abstract][Full Text] [Related]
17. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling. Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671 [TBL] [Abstract][Full Text] [Related]
18. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases. Pan-Montojo F; Funk RH CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153 [TBL] [Abstract][Full Text] [Related]
19. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313 [TBL] [Abstract][Full Text] [Related]